Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014583 |
| CAS No | NA |
| Mol.F. | C29H37N5O11 |
| Mol.Wt. | 631.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014584 |
| CAS No | NA |
| Mol.F. | C35H37N5O7 |
| Mol.Wt. | 639.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014585 |
| CAS No | NA |
| Mol.F. | C18H26ClN5O6S |
| Mol.Wt. | 475.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014586 |
| CAS No | 959007-11-5 |
| Mol.F. | C14H9ClN2O |
| Mol.Wt. | 256.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014587 |
| CAS No | 41075-14-3 |
| Mol.F. | C14H10Cl2N2O |
| Mol.Wt. | 293.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014588 |
| CAS No | NA |
| Mol.F. | C22H29ClN4O |
| Mol.Wt. | 401.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014589 |
| CAS No | NA |
| Mol.F. | C16H14N2O2 |
| Mol.Wt. | 266.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014590 |
| CAS No | NA |
| Mol.F. | C14H13N3O |
| Mol.Wt. | 239.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014591 |
| CAS No | 63819-70-5 |
| Mol.F. | C8H18N2O |
| Mol.Wt. | 158.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014592 |
| CAS No | NA |
| Mol.F. | C11H13ClN6O3 |
| Mol.Wt. | 312.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014593 |
| CAS No | NA |
| Mol.F. | C10H13N3O5 |
| Mol.Wt. | 255.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014594 |
| CAS No | NA |
| Mol.F. | C11H8F3N3O |
| Mol.Wt. | 255.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014595 |
| CAS No | NA |
| Mol.F. | C15H16N4O3S |
| Mol.Wt. | 332.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014596 |
| CAS No | NA |
| Mol.F. | C12H8N4O3S |
| Mol.Wt. | 288.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014597 |
| CAS No | NA |
| Mol.F. | C12H9N3O2S |
| Mol.Wt. | 259.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014598 |
| CAS No | NA |
| Mol.F. | C13H15N3O |
| Mol.Wt. | 229.3 |
| INV STATUS | CUSTOM SYNTHESIS |